Guggenheim Capital LLC Neurocrine Biosciences Inc Transaction History

Guggenheim Capital LLC

  • $13.3 Billion
  • Q3 2025

A detailed history of Guggenheim Capital LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 22,288 shares of NBIX stock, worth $3.23 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
22,288
Previous 22,924 2.77%
Holding current value
$3.23 Million
Previous $2.88 Million 8.57%
% of portfolio
0.02%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$123.98 - $146.67 $78,851 - $93,282
-636 Reduced 2.77%
22,288 $3.13 Million
Q2 2025

Aug 13, 2025
SELL
$87.54 - $128.18 $118,616 - $173,683
-1,355 Reduced 5.58%
22,924 $2.88 Million
Q1 2025

May 14, 2025
BUY
$107.22 - $153.29 $148,070 - $211,693
1,381 Added 6.03%
24,279 $2.69 Million
Q4 2024

Feb 13, 2025
SELL
$111.62 - $139.44 $1.02 Million - $1.27 Million
-9,134 Reduced 28.52%
22,898 $3.13 Million
Q3 2024

Nov 13, 2024
SELL
$114.58 - $153.15 $2.08 Million - $2.77 Million
-18,115 Reduced 36.12%
32,032 $3.69 Million
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $1.65 Million - $1.81 Million
12,629 Added 33.66%
50,147 $6.9 Million
Q1 2024

May 14, 2024
BUY
$130.4 - $143.74 $1.12 Million - $1.23 Million
8,579 Added 29.65%
37,518 $5.17 Million
Q4 2023

Feb 14, 2024
SELL
$106.07 - $132.76 $1.08 Million - $1.35 Million
-10,169 Reduced 26.0%
28,939 $3.81 Million
Q3 2023

Nov 14, 2023
SELL
$94.02 - $117.1 $487,775 - $607,514
-5,188 Reduced 11.71%
39,108 $4.4 Million
Q2 2023

Aug 11, 2023
BUY
$89.53 - $104.87 $216,214 - $253,261
2,415 Added 5.77%
44,296 $4.18 Million
Q1 2023

May 10, 2023
SELL
$94.11 - $123.02 $24,939 - $32,600
-265 Reduced 0.63%
41,881 $4.24 Million
Q4 2022

Feb 14, 2023
SELL
$106.72 - $127.06 $144,178 - $171,658
-1,351 Reduced 3.11%
42,146 $5.03 Million
Q3 2022

Nov 14, 2022
SELL
$92.03 - $107.81 $348,057 - $407,737
-3,782 Reduced 8.0%
43,497 $4.62 Million
Q2 2022

Aug 15, 2022
SELL
$75.79 - $100.07 $758,127 - $1 Million
-10,003 Reduced 17.46%
47,279 $4.61 Million
Q1 2022

May 16, 2022
SELL
$72.45 - $94.81 $355,005 - $464,569
-4,900 Reduced 7.88%
57,282 $5.37 Million
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $274,712 - $366,352
3,449 Added 5.87%
62,182 $5.3 Million
Q3 2021

Nov 15, 2021
SELL
$86.18 - $99.03 $113,929 - $130,917
-1,322 Reduced 2.2%
58,733 $5.63 Million
Q2 2021

Aug 13, 2021
BUY
$89.43 - $102.27 $814,349 - $931,270
9,106 Added 17.87%
60,055 $5.85 Million
Q1 2021

May 13, 2021
BUY
$87.57 - $119.4 $1.06 Million - $1.44 Million
12,056 Added 31.0%
50,949 $4.96 Million
Q4 2020

Feb 16, 2021
BUY
$86.91 - $108.33 $30,592 - $38,132
352 Added 0.91%
38,893 $3.73 Million
Q3 2020

Nov 13, 2020
SELL
$96.16 - $135.15 $575,132 - $808,332
-5,981 Reduced 13.43%
38,541 $3.71 Million
Q2 2020

Aug 14, 2020
BUY
$85.09 - $130.36 $356,101 - $545,556
4,185 Added 10.38%
44,522 $5.43 Million
Q1 2020

Jun 02, 2020
SELL
$75.11 - $113.76 $665,474 - $1.01 Million
-8,860 Reduced 18.01%
40,337 $3.49 Million
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $685,372 - $936,228
7,896 Added 19.12%
49,197 $5.29 Million
Q3 2019

Nov 14, 2019
SELL
$83.82 - $101.5 $735,604 - $890,764
-8,776 Reduced 17.53%
41,301 $3.72 Million
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $499,178 - $630,675
-6,910 Reduced 12.13%
50,077 $4.23 Million
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $28,001 - $36,978
404 Added 0.71%
56,987 $5.02 Million
Q4 2018

Feb 14, 2019
BUY
$68.32 - $124.36 $354,580 - $645,428
5,190 Added 10.1%
56,583 $4.04 Million
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $428,150 - $544,930
-4,330 Reduced 7.77%
51,393 $6.32 Million
Q2 2018

Aug 14, 2018
SELL
$75.3 - $105.99 $195,177 - $274,726
-2,592 Reduced 4.44%
55,723 $5.47 Million
Q1 2018

May 15, 2018
SELL
$75.88 - $92.43 $572,135 - $696,922
-7,540 Reduced 11.45%
58,315 $4.84 Million
Q4 2017

Feb 14, 2018
SELL
$58.53 - $77.59 $1.55 Million - $2.06 Million
-26,490 Reduced 28.69%
65,855 $5.11 Million
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $4.43 Million - $5.66 Million
92,345
92,345 $5.66 Million

Others Institutions Holding NBIX

# of Institutions
744
Shares Held
103M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email